Elite Pharmaceuticals Inc (ELTP)

[Couch]

Anyone familiar with the M&A process is well aware that timing is critical and acquirers always seek to acquire as cheaply as possible. A sober viewing of this situation would leave a strategist convinced that now is the time to buy the company.

I agree with most everything in your post and how well thought out it is perhaps except only the above. While I understand what you are hitting at and why, in essence, given what you mention the company put the poison pill in place to and structured the board the way it has to prevent a cheap or even hostile buyout.....however, I believe other more senior major pharma companies such as Pfizer, JnJ, Actavis, and Merck for instance, do not need to low ball a company to purchase it......they are more than willing to wait for Elite to put out one or two of its ADT products to see if the science behind it works on the market and equally if not more important how the market responds from a financial standpoint.....And then and only then buyout the company IMO for a "usual" say 40% mark up. This year prior to a ART launch will be nowhere near $6-8. We would be lucky to get $1.50 before Elite launches its first abuse deterrent product.